Follow us

Experience

Indivior plc

in connection with the Relationship Agreement and settlement reached with the Company’s largest shareholder, the activist investor Scopia Management

Parkinson's UK

on its acquisition of assets relating to the research, development, manufacture and marketing of glial-cell line-derived neurotrophic factor (GDNF), a potentially disease-modifying treatment for Parkinson's disease

SK Holdings

on its acquisition of Yposkesi, a French market leader in gene therapy and viral vector manufacturing

Acacia Research Corporation

on its entry into an agreement with Link Fund Solutions Limited to purchase shares in up to 19 public and private life sciences companies from the LF Equity Income Fund for up to £223.9 million.

Mirnagreen

 in relation to the launch and correct classification of new products based on a disruptive technology for extracting microRNA from plants, including advising on strategy to mitigate risks related to a misclassification under the contiguous categories of medicinal products, novel food and food supplements

Read more

FederFARMACO

a company representing pharmaceutical wholesalers, on regulatory affairs and intellectual property matters

Pharmaceuticals and healthcare

Insight not hindsight

Life science notes blog

Find analysis of the latest legal developments relevant to the life sciences

Key contacts

Alan Montgomery photo

Alan Montgomery

Partner, Co-Head Pharmaceuticals, Co-Head of India Practice, London

Alan Montgomery
Chris Parker KC photo

Chris Parker KC

Partner, Co-Head Pharmaceuticals, London

Chris Parker KC
Natalie Bryce photo

Natalie Bryce

Partner, Brisbane

Natalie Bryce